BioMark Expands Its Liquid Biopsy Platform Receptor Status for Breast Cancer Vancouver, British Columbia--( - December 10, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ...
The use of hormone replacement therapy (HRT) increases the risk of breast cancer. The increased breast cancer risk is greater for combined estrogen–progestin therapies than for estrogen-only ...